NasdaqGM - Delayed Quote USD
Clearside Biomedical, Inc. (CLSD)
0.7600
+0.0250
+(3.40%)
At close: June 4 at 4:00:01 PM EDT
0.7401
-0.02
(-2.62%)
After hours: June 4 at 7:31:09 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 7 |
| Avg. Estimate | -0.1 | -0.09 | -0.41 | -0.61 |
| Low Estimate | -0.12 | -0.13 | -0.63 | -1.3 |
| High Estimate | -0.08 | -0.07 | -0.18 | -0.2 |
| Year Ago EPS | -0.1 | -0.1 | -0.47 | -0.41 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 7 |
| Avg. Estimate | 498.43k | 498.57k | 3.97M | 3.43M |
| Low Estimate | -- | -- | 2.3M | -- |
| High Estimate | 2.3M | 2.3M | 10.3M | 20.29M |
| Year Ago Sales | 90k | 1.04M | 1.66M | 3.97M |
| Sales Growth (year/est) | 453.81% | -51.97% | 138.58% | -13.66% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.14 | -0.12 | -0.1 | -0.11 |
| EPS Actual | -0.1 | -0.1 | -0.1 | -0.11 |
| Difference | 0.04 | 0.02 | 0 | -0 |
| Surprise % | 25.93% | 19.54% | 3.22% | -3.12% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.1 | -0.09 | -0.41 | -0.61 |
| 7 Days Ago | -0.1 | -0.09 | -0.41 | -0.65 |
| 30 Days Ago | -0.11 | -0.1 | -0.45 | -0.59 |
| 60 Days Ago | -0.09 | -0.12 | -0.46 | -0.52 |
| 90 Days Ago | -0.09 | -0.12 | -0.44 | -0.54 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 2 | 1 | -- |
| Up Last 30 Days | 1 | 2 | 5 | -- |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CLSD | -2.86% | 7.14% | 13.37% | -49.83% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.97% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/23/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 5/16/2025 |
| Maintains | Needham: Buy to Buy | 5/15/2025 |
| Reiterates | Needham: Buy to Buy | 4/8/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/31/2025 |
| Reiterates | Citizens Capital Markets: Market Outperform to Market Outperform | 3/28/2025 |
Related Tickers
LPTX Leap Therapeutics, Inc.
0.4049
+9.28%
OVID Ovid Therapeutics Inc.
0.3096
+3.65%
RGNX REGENXBIO Inc.
10.08
-0.49%
EYPT EyePoint Pharmaceuticals, Inc.
8.20
+0.99%
CNTX Context Therapeutics Inc.
0.5753
-1.15%
OCUL Ocular Therapeutix, Inc.
8.38
+0.60%
ADVM Adverum Biotechnologies, Inc.
2.4700
-1.59%
ELEV Elevation Oncology, Inc.
0.3042
-0.23%
FBLG FibroBiologics, Inc.
0.8498
+7.77%
KPTI Karyopharm Therapeutics Inc.
4.3400
+2.12%